Clinical trial
Open access
Sep 2026
Multidimensional efficacy characterization of xeligekimab in moderate-to-severe plaque psoriasis: regional responses, treatment targets, and patient-reported outcomes from a randomized controlled trial
Xeligekimab provides rapid symptom resolution across all clinical dimensions, high and sustained achievement of treatment targets, and comprehensive restoration of quality of life in Chinese patients.
Kun Huang, Yi Zhao, Chun-Jun Yang et al.
· Frontiers in Immunology · 0 citations